ZEB2 and diabetic kidney disease: Mechanistic studies have indicated that miR-192-5p promotes TGF-β-induced collagen deposition in diabetic kidneys disease by targeting the E-box repressor, SMAD-interacting protein 1 (SIP1) (Kato et al., 2007).